1. Home
  2. REPL vs LTBR Comparison

REPL vs LTBR Comparison

Compare REPL & LTBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

HOLD

Current Price

$10.04

Market Cap

721.7M

Sector

Health Care

ML Signal

HOLD

Logo Lightbridge Corporation

LTBR

Lightbridge Corporation

HOLD

Current Price

$14.77

Market Cap

578.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
REPL
LTBR
Founded
2015
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
721.7M
578.2M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
REPL
LTBR
Price
$10.04
$14.77
Analyst Decision
Buy
Analyst Count
9
0
Target Price
$12.00
N/A
AVG Volume (30 Days)
1.7M
1.1M
Earning Date
11-06-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.68
$4.37
52 Week High
$14.80
$31.34

Technical Indicators

Market Signals
Indicator
REPL
LTBR
Relative Strength Index (RSI) 57.68 38.24
Support Level $9.63 $15.68
Resistance Level $10.29 $17.19
Average True Range (ATR) 0.59 1.13
MACD -0.10 0.14
Stochastic Oscillator 35.42 12.16

Price Performance

Historical Comparison
REPL
LTBR

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

About LTBR Lightbridge Corporation

Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through one business segment, which is the development and commercialization of its nuclear fuel. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.

Share on Social Networks: